Sphera Funds Management as of Sept. 30, 2014
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 128 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Novartis (NVS) | 5.6 | $45M | 479k | 94.14 | |
| Spdr S&p Oil & Gas Exp & Pr put | 4.9 | $39M | 200k | 197.02 | |
| Pfizer (PFE) | 4.7 | $38M | 1.3M | 29.57 | |
| Teva Pharmaceutical Industries (TEVA) | 4.3 | $35M | 647k | 53.89 | |
| Select Sector Spdr Tr option | 3.8 | $31M | 486k | 63.91 | |
| Actavis | 3.6 | $30M | 122k | 241.28 | |
| Merck & Co (MRK) | 3.1 | $25M | 418k | 59.28 | |
| Abbvie (ABBV) | 2.9 | $23M | 404k | 57.76 | |
| Allergan Inc Com Stk | 2.8 | $23M | 129k | 178.19 | |
| Shire | 2.8 | $22M | 259k | 86.57 | |
| Johnson & Johnson (JNJ) | 2.7 | $22M | 207k | 106.59 | |
| Isram | 2.7 | $22M | 103M | 0.21 | |
| Gilead Sciences Inc option | 2.6 | $21M | 194k | 106.45 | |
| Teva Pharmaceutical Inds Ltd option | 2.5 | $20M | 375k | 53.75 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $17M | 150k | 112.31 | |
| Glaxosmithkline | 1.7 | $13M | 291k | 45.97 | |
| Valeant Pharmaceuticals Int | 1.6 | $13M | 99k | 131.20 | |
| VALEANT PHARMACEUTICALS Inte call | 1.6 | $13M | 97k | 131.20 | |
| Mallinckrodt Pub | 1.5 | $12M | 136k | 90.15 | |
| United Therapeutics Corporation (UTHR) | 1.4 | $11M | 89k | 128.65 | |
| Israel Chemicals | 1.2 | $10M | 1.4M | 7.23 | |
| Elbit Systems (ESLT) | 1.1 | $9.0M | 145k | 61.99 | |
| Orbotech Ltd Com Stk | 1.1 | $8.9M | 572k | 15.57 | |
| BioMarin Pharmaceutical (BMRN) | 1.1 | $8.8M | 122k | 72.16 | |
| Astrazeneca | 1.1 | $8.6M | 120k | 71.44 | |
| Verint Systems (VRNT) | 1.0 | $8.4M | 152k | 55.61 | |
| Sanofi Aventis Wi Conval Rt | 0.9 | $7.7M | 68k | 113.14 | |
| Salix Pharmaceuticals Inc option | 0.9 | $7.6M | 49k | 156.25 | |
| Puma Biotechnology (PBYI) | 0.9 | $7.2M | 30k | 238.58 | |
| Astrazeneca Plc-spons Adr call | 0.9 | $6.9M | 97k | 71.44 | |
| Amgen | 0.8 | $6.8M | 49k | 140.45 | |
| Acorda Therapeutics | 0.8 | $6.7M | 199k | 33.88 | |
| Eli Lilly & Co. (LLY) | 0.8 | $6.3M | 97k | 64.85 | |
| Medivation | 0.8 | $6.2M | 63k | 98.87 | |
| B Communications (BCOMF) | 0.8 | $6.2M | 321k | 19.21 | |
| MedAssets | 0.8 | $6.1M | 434k | 14.07 | |
| Seattle Genetics | 0.7 | $5.8M | 155k | 37.18 | |
| Dyax | 0.7 | $5.2M | 518k | 10.12 | |
| Apple Computer | 0.6 | $5.0M | 50k | 100.75 | |
| Ituran Location And Control (ITRN) | 0.6 | $4.9M | 231k | 21.03 | |
| AMAG Pharmaceuticals | 0.6 | $4.8M | 150k | 31.91 | |
| Clovis Oncology | 0.6 | $4.6M | 102k | 45.36 | |
| Pharmacyclics | 0.6 | $4.6M | 39k | 117.43 | |
| CSX Corporation (CSX) | 0.6 | $4.5M | 140k | 32.06 | |
| Mylan | 0.6 | $4.4M | 97k | 45.49 | |
| GlaxoSmithKline | 0.6 | $4.5M | 97k | 45.97 | |
| Auspex Pharmaceuticals | 0.5 | $4.2M | 165k | 25.67 | |
| Broadcom Corporation | 0.5 | $4.0M | 99k | 40.42 | |
| Applied Genetic Technol Corp C | 0.5 | $3.9M | 211k | 18.61 | |
| NPS Pharmaceuticals | 0.5 | $3.6M | 139k | 26.00 | |
| Union Pacific Corporation (UNP) | 0.4 | $3.5M | 32k | 108.41 | |
| Intercept Pharmaceuticals In | 0.4 | $3.4M | 15k | 236.66 | |
| Tokai Pharmaceuticals | 0.4 | $3.5M | 230k | 15.14 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.4 | $3.4M | 200k | 17.19 | |
| Aerie Pharmaceuticals | 0.4 | $3.4M | 164k | 20.69 | |
| Cymabay Therapeutics | 0.4 | $3.4M | 490k | 6.84 | |
| Health Care SPDR (XLV) | 0.4 | $3.1M | 49k | 63.91 | |
| V.F. Corporation (VFC) | 0.4 | $3.2M | 48k | 66.03 | |
| CVS Caremark Corporation (CVS) | 0.4 | $3.2M | 40k | 79.58 | |
| Array BioPharma | 0.4 | $3.1M | 874k | 3.57 | |
| Salix Pharmaceuticals | 0.4 | $3.1M | 20k | 156.25 | |
| Radius Health | 0.4 | $3.2M | 150k | 21.00 | |
| Incyte Corporation (INCY) | 0.4 | $3.0M | 61k | 49.06 | |
| Tjx Cos | 0.4 | $3.0M | 50k | 59.18 | |
| AVANIR Pharmaceuticals | 0.4 | $3.0M | 250k | 11.92 | |
| Acceleron Pharma | 0.4 | $3.0M | 100k | 30.24 | |
| Yum! Brands (YUM) | 0.4 | $2.9M | 40k | 71.99 | |
| Schlumberger (SLB) | 0.4 | $2.9M | 29k | 101.70 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $2.8M | 64k | 44.01 | |
| Towers Watson & Co | 0.3 | $2.8M | 28k | 99.50 | |
| Sage Therapeutics (SAGE) | 0.3 | $2.8M | 88k | 31.50 | |
| Otonomy | 0.3 | $2.7M | 111k | 24.00 | |
| Colgate-Palmolive Company (CL) | 0.3 | $2.6M | 40k | 65.21 | |
| Nice Systems (NICE) | 0.3 | $2.6M | 65k | 40.62 | |
| Google Inc Class C | 0.3 | $2.6M | 4.5k | 577.31 | |
| Ironwood Pharmaceuticals (IRWD) | 0.3 | $2.5M | 194k | 12.96 | |
| 0.3 | $2.2M | 3.8k | 588.53 | ||
| Vanda Pharmaceuticals (VNDA) | 0.3 | $2.3M | 218k | 10.38 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.3 | $2.3M | 686k | 3.32 | |
| Macrogenics (MGNX) | 0.3 | $2.3M | 108k | 20.90 | |
| La Jolla Pharmaceuticl Com Par | 0.3 | $2.1M | 223k | 9.61 | |
| Arena Pharmaceuticals | 0.3 | $2.1M | 500k | 4.19 | |
| Trevena | 0.3 | $2.1M | 331k | 6.42 | |
| Immunomedics | 0.2 | $2.0M | 534k | 3.72 | |
| Relypsa | 0.2 | $2.0M | 97k | 21.09 | |
| Akebia Therapeutics (AKBA) | 0.2 | $2.0M | 90k | 22.13 | |
| MasterCard Incorporated (MA) | 0.2 | $1.9M | 26k | 73.92 | |
| Snap-on Incorporated (SNA) | 0.2 | $1.9M | 16k | 121.06 | |
| Bluebird Bio (BLUE) | 0.2 | $1.9M | 53k | 35.88 | |
| Celladon | 0.2 | $1.9M | 186k | 10.46 | |
| Kite Pharma | 0.2 | $1.9M | 68k | 28.50 | |
| Zafgen | 0.2 | $1.9M | 97k | 19.65 | |
| Actinium Pharmaceuticals | 0.2 | $2.0M | 291k | 6.70 | |
| Alder Biopharmaceuticals | 0.2 | $1.9M | 150k | 12.68 | |
| Ellomay Capital (ELLO) | 0.2 | $1.9M | 191k | 9.89 | |
| Prosensa Hldgs B V Shs Usd | 0.2 | $1.8M | 219k | 8.43 | |
| Oncomed Pharmaceuticals | 0.2 | $1.8M | 97k | 18.93 | |
| Marinus Pharmaceuticals | 0.2 | $1.9M | 294k | 6.47 | |
| Mannkind Corp Common Stock cmn | 0.2 | $1.8M | 300k | 5.91 | |
| TJX Companies (TJX) | 0.2 | $1.6M | 28k | 59.17 | |
| Acelrx Pharmaceuticals | 0.2 | $1.6M | 290k | 5.49 | |
| Ignyta | 0.2 | $1.6M | 199k | 8.06 | |
| Receptos | 0.2 | $1.6M | 25k | 62.12 | |
| Ocera Therapeutics | 0.2 | $1.6M | 321k | 4.90 | |
| Epizyme | 0.2 | $1.4M | 50k | 27.12 | |
| Cytokinetics (CYTK) | 0.2 | $1.3M | 363k | 3.52 | |
| Genvec | 0.1 | $1.2M | 558k | 2.08 | |
| Auris Med Hldg | 0.1 | $1.1M | 191k | 5.81 | |
| Bio Blast Pharma | 0.1 | $1.1M | 150k | 7.27 | |
| Palatin Technologies | 0.1 | $1.0M | 1.1M | 0.93 | |
| Affimed Therapeutics B V | 0.1 | $945k | 150k | 6.30 | |
| Discovery Laboratories | 0.1 | $893k | 486k | 1.84 | |
| Alcobra | 0.1 | $866k | 56k | 15.44 | |
| Oncothyreon | 0.1 | $822k | 428k | 1.92 | |
| Tetrelogic Pharmaceuticals (TLOG) | 0.1 | $808k | 194k | 4.16 | |
| Zs Pharma | 0.1 | $811k | 21k | 39.21 | |
| INSTRS INC Stemcells | 0.1 | $612k | 486k | 1.26 | |
| Prothena (PRTA) | 0.1 | $663k | 30k | 22.17 | |
| Kalobios Pharmaceuticals | 0.1 | $542k | 350k | 1.55 | |
| Ormat Technologies (ORA) | 0.1 | $522k | 20k | 26.25 | |
| Biolinerx Ltd-spons | 0.0 | $298k | 193k | 1.54 | |
| Concert Pharmaceuticals I equity | 0.0 | $286k | 23k | 12.60 | |
| Brainstorm Cell Therapeutics (BCLI) | 0.0 | $265k | 63k | 4.18 | |
| Summit Financial | 0.0 | $63k | 25k | 2.52 | |
| Tetraphase Pharmaceuticals | 0.0 | $47k | 2.4k | 19.87 | |
| Macrocure | 0.0 | $51k | 7.1k | 7.18 | |
| Auxilium Pharmaceuticals | 0.0 | $30k | 1.0k | 30.00 | |
| Agios Pharmaceuticals (AGIO) | 0.0 | $25k | 405.00 | 61.73 |
